Frontage Laboratories, Inc

📣 Exciting news! Frontage has once again been named a CRO Leadership Awards recipient by Clinical Leader and Life Science Leader magazine! Frontage received five awards across all categories, including Capabilities, Compatibility, Expertise, Quality, and Reliability, across all three groups of respondents (Big Pharma, Small Pharma, and Overall (combined Big and Small Pharma)). In the Compatibility category, Frontage was given additional recognition as a CRO Leadership Award Champion for scoring as a top performer compared to the weighted average of other CROs included in ISR’s annual CRO Quality Benchmarking survey. 👉 Check out our latest press release for more details: http://ow.ly/yuCs50NVaqL Partner with Frontage for your next drug discovery and development project to see what all the buzz is about! #croleadershipawards #cro #drugdiscovery #drugdevelopment #pharma

Given that the average drug can take up to 15 years and costs nearly USD 2 billion to get to market, thorough and efficient testing during the early stages can save you both time and money. Frontage's early drug discovery services provide comprehensive support to help drive your compound from hit screening and identification to drug candidate selection. 👉Download our latest fact sheet to learn more: https://ow.ly/pQBj50RlyZQ #drugdiscovery #cro #pharma

Given that the average drug can take up to 15 years and costs nearly USD 2 billion to get to market, thorough and efficient testing during the early stages can save you both time and money. Frontage's early drug discovery services provide comprehensive support to help drive your compound from hit screening and identification to drug candidate selection. 👉Download our latest fact sheet to learn more: https://ow.ly/pQBj50RlyZQ #drugdiscovery #cro #pharma #EarlyDrugDiscovery #DrugCandidate #DrugDevelopment #Biotech #Pharmaceuticals #ClinicalTrials

Headed to EMGS next week? Come see Javed Bhalli present Poster # PS116 on 𝗚𝗲𝗻𝗼𝘁𝗼𝘅𝗶𝗰 𝗣𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹 𝗼𝗳 𝗮𝗻 𝗔𝗻𝘁𝗶𝘃𝗶𝗿𝗮𝗹 𝗣𝘆𝗿𝗶𝗺𝗶𝗱𝗶𝗻𝗲 𝗡𝘂𝗰𝗹𝗲𝗼𝘀𝗶𝗱𝗲 𝗔𝗻𝗮𝗹𝗼𝗴𝘂𝗲, 𝟱-(𝟮-𝗰𝗵𝗹𝗼𝗿𝗼𝗲𝘁𝗵𝘆𝗹)-𝟮′-𝗱𝗲𝗼𝘅𝘆𝘂𝗿𝗶𝗱𝗶𝗻𝗲 (𝗖𝗘𝗗𝗨). This presentation will be about a recent Pig-a and micronucleus study conducted in rats to demonstrate the genotoxic potential of CEDU. It was determined that CEDU is a strong gene mutagen but does not cause clastogenicity or aneugenicity. 👉Poster # PS116 👉Date: September 9, 2024 👉Location: Palm Springs, CA Interested in learning more? Email us at sales@frontagelab.com to speak with a scientific expert. We hope to see you in California!

As your solutions partner, Frontage commits to delivering the insights needed for successful CAR-T projects through our comprehensive biomarker and flow cytometry programs. We offer extensive experience and advanced technology in biomarker assay development, validation, and testing, adhering to CAP, CLIA, GLP, and GCLP standards. Take a look at our latest fact sheet for more information on CAR-T Cell Therapy Services at Frontage. 👉 Download Now: https://ow.ly/VBqj50QL3OC #drugdevelopment #biomarkers #drugdiscovery #cro

Why partner with Frontage for your next project? At Frontage, we offer rigorous scientific expertise and high-quality standards to solve your most complex challenges at every stage of drug discovery and development. We are focused on meeting your project needs on time, on spec, and on budget. 👉Don't hesitate to reach out, share your project details, and get a quote from us: https://ow.ly/9UUq50QwiHJ

Headed to CABS 2024 BioPacific Conference this week? Stop by Booth # 20 to meet with members from our Global Drug Discovery and Bioanalytical teams to learn how Frontage Laboratories can be the perfect fit for your drug development needs! 👉Date: September 7, 2024 @ 8:00 am – @ 8:00 pm. 👉Location: South San Francisco Conference Center, 255 S Airport Blvd, South San Francisco, CA 94080. 👉Booth # 20 Interested in meeting with our team? Email us at sales@frontagelab.com to speak with a scientific expert. We hope to see you in California!

At Frontage, to support your drug candidate evaluation process, our scientific staff provides comprehensive Drug Metabolism and Pharmacokinetics (DMPK) services, applying state-of-the-art techniques and best-in-class approaches to generate data for critical milestones and decision-making during drug discovery and development. Our highly trained and experienced scientific team provides broad and in-depth expertise/advice to clients on appropriate study designs, execution of studies, and interpretation of the data. 👉 Learn more: https://ow.ly/otxy50T4vv0 📣 Are you attending ISSX in Hawaii this month? Our DMPK group will be on hand at booth # 202, Interested in connecting before the event? Email us at: sales@frontagelab.com #DrugMetabolism #Pharmacokinetics #DMPKservices #DrugDiscovery #ISSXHawaii

Gain access to comprehensive biologics services in support of advanced development programs with Frontage's bioanalytical laboratory. We can analyze virtually any peptide, protein or antibody, and have built a reputation for solving technical challenges related to assay development and validation. Check out our Large Molecule services fact sheet for more info. 👉 Download Now: https://ow.ly/4uXs50T4uyx #BiologicsServices #BioanalyticalLaboratory #AssayDevelopment #AssayValidation #LargeMoleculeServices #BiotechSolutions #LifeScienceResearch

When it comes to Alzheimer's Disease, early and accurate diagnosis is critical for the effective treatment and management of the disease. Currently, early AD diagnosis and management are largely guided by clinical symptoms. FDA-approved neuroimaging and cerebrospinal fluid (CSF) biomarkers can aid detection and diagnosis; however, the clinical implementation of these testing modalities is limited due to the availability, cost, and perceived invasiveness. Measuring blood-based biomarkers instead offers a simple, cost-effective, accessible, and scalable approach to AD research, diagnosis, and progression monitoring, which can be an extremely valuable first step in accurate diagnosis for the disease. At Frontage, our Bioanalytical Team is highly experienced in developing, qualifying, and validating biomarker assays associated with Alzheimer's Disease. 👉Learn more by downloading our latest fact sheet here: https://ow.ly/yZyW50SNasy #biomarkers #bioanalysis #alzheimers #drugdevelopment